Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C McNeil

Showing results (51-60 of 130) with videos related to

Pageof 13
Sort By:
Journal of the National Cancer Institute|July 16, 1997
Are changes in end-of-life cancer care coming? IOM, ASCO tackle issuesC McNeil
Journal of the National Cancer Institute|May 4, 2000
Herceptin in the adjuvant setting: phase III trials beginC McNeil
Journal of the National Cancer Institute|December 7, 2000
Consensus panel endorses range of adjuvant therapies for breast cancerC McNeil
Journal of the National Cancer Institute|November 15, 1995
A new generation of monoclonal antibodies arrives at the clinicC McNeil
Journal of the National Cancer Institute|June 21, 1995
Ovarian cancer: latest gains establish new battle frontsC McNeil
Journal of the National Cancer Institute|October 23, 1997
Vitamins during pregnancy linked to lower risk of childhood brain tumorsC McNeil
Journal of the National Cancer Institute|December 9, 1997
HPV vaccines for cervical cancer move toward clinic, encounter social issuesC McNeil
Journal of Palliative Care|January 1, 1991
From migration to palliation: uncharted watersC McNeil
The Medical Officer|March 19, 2010
Infantile mortalityC McNEIL
Journal of the National Cancer Institute|June 5, 1996
Why patients enroll in clinical trials: physicians play a key roleC McNeil
Pageof 13

Showing results (51-60 of 130) with videos related to

Sort By:
Pageof 13
Journal of the National Cancer Institute|July 16, 1997
Are changes in end-of-life cancer care coming? IOM, ASCO tackle issuesC McNeil
Journal of the National Cancer Institute|May 4, 2000
Herceptin in the adjuvant setting: phase III trials beginC McNeil
Journal of the National Cancer Institute|December 7, 2000
Consensus panel endorses range of adjuvant therapies for breast cancerC McNeil
Journal of the National Cancer Institute|November 15, 1995
A new generation of monoclonal antibodies arrives at the clinicC McNeil
Journal of the National Cancer Institute|June 21, 1995
Ovarian cancer: latest gains establish new battle frontsC McNeil
Journal of the National Cancer Institute|October 23, 1997
Vitamins during pregnancy linked to lower risk of childhood brain tumorsC McNeil
Journal of the National Cancer Institute|December 9, 1997
HPV vaccines for cervical cancer move toward clinic, encounter social issuesC McNeil
Journal of Palliative Care|January 1, 1991
From migration to palliation: uncharted watersC McNeil
The Medical Officer|March 19, 2010
Infantile mortalityC McNEIL
Journal of the National Cancer Institute|June 5, 1996
Why patients enroll in clinical trials: physicians play a key roleC McNeil
Pageof 13